My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Fri 27 Nov 2009 | 4:46 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Salix Pharmaceuticals Ltd
Salix Pharmaceuticals Ltd (SLXP.O) (Nasdaq)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
SLXP
on other exchanges
As of 25 Nov 2009
23.29
USD
Price Change
+0.00
Percent Change
+0.00%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Forbes, William
47
2005
Vice President - Research and Development, Chief Development Officer
Logan, Carolyn
60
2002
President, Chief Executive Officer, Director
D'Alonzo, Thomas
65
2000
Director
Franco, Richard
68
2000
Director
Keane, William
54
2004
Director
Sirgo, Mark
55
2008
Director
Derbyshire, Adam
43
2000
Chief Financial Officer, Senior Vice President - Finance and Administration
Chappell, John
72
2003
Chairman of the Board
Find out more about SLXP.O
Insider Trading